Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-088543
Filing Date
2025-06-20
Accepted
2025-06-20 16:31:20
Documents
2
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1518
2 EX-24 nuvl-ex24.htm EX-24 14247
  Complete submission text file 0000950170-25-088543.txt   17152
Mailing Address 85 WELLS AVENUE SUITE 210 NEWTON MA 02459
Business Address
Oliger Christy J. (Reporting) CIK: 0001822092 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40671 | Film No.: 251061879

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)